Perlara
YC W16 · Active · Perlara: building the YC for rare disease parents
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCW22 | |
| Other | Not stated | Antler2022 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
| AI | Active | YCS19 | |
| AI | Active | YCX26 | |
| AI | Active | YCW23 | |
| AI | Active | YCS15 | |
| Other | Acquired | YCS18 |
Also from W16
All of W16About Perlara
Perlara 1.0 (Feb 2014 - Feb 2019) launched early R&D joint ventures called PerlQuests with highly motivated rare disease families, companies or impact investors. We screened gene-edited patient avatars for repurposable drugs in order to build a predictive R&D engine called ArkBase. We planned to monetize programs based on ArkBase predictions by selectively spinning out asset-centric clinical development NewCos. Perlara 1.5 (March 2019 - April 2020) was the transition to a one-person virtual clinical development company and when the epalrestat and aripiprazole repurposing trials were launched at Mayo Clinic for the treatment of PMM2-CDG and NGLY1-CDDG, respectively. Perlara 2.0 (May 2020 --> The first decentralized and distributed biotech
- YC batch
- W16 · Winter 2016
- Status, per YC
- Active
- Category
- Other
- Team size
- 1
- Location
- San Francisco, CA, USA; Oakland, CA, USA; Remote
- Checked
- 33m ago
Perlara: questions
Which YC batch was Perlara in?
Perlara was in Y Combinator's Winter 2016 batch (W16).
Is Perlara still active?
Y Combinator lists Perlara as active.
Where is Perlara based?
Perlara lists San Francisco, CA, USA; Oakland, CA, USA; Remote as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.